Consistent with the findings of the present study, TER ATPase has also been reported in EVs released from various cancer cells [47] and its downregulation greatly reduces exosome secretion, suggesting targeting of TER ATPase as a new anti-tumor therapy approach [48]. This evidence concerns the gene VCP and cancer.